@MookyTroubadour "the asthma inhaler business was hindered by “unwarranted opposition to PMI’s transformation” from a Big Tobacco stalwart into a broadly based health company."

Maybe because they didn't stop selling their tobacco products? Perhaps that could have been what led people to be skeptical of a company selling one product that causes a disease which is treated by another product they sell.